Literature DB >> 27373500

The association of clinical parameters and ultrasound verified inflammation with patients' and physicians' global assessments in psoriatic arthritis.

Angelika Lackner1, Christina Duftner2, Anja Ficjan1, Judith Gretler1, Josef Hermann1, Rusmir Husic1, Winfried B Graninger1, Christian Dejaco3.   

Abstract

OBJECTIVES: To study the association of clinical and/or ultrasound variables with patients' (PGA) and physicians' (EGA) global assessment of disease activity in psoriatic arthritis (PsA). The correlation of these parameters with the discordance between PGA and EGA, as well as with PGA/EGA changes over 6 months was also investigated.
METHODS: Prospective study of 83 consecutive PsA patients with 2 visits scheduled 6 months apart. All patients underwent the following assessments: tender (TJC) and swollen joint count (SJC), PASI, dactylitis and Leeds enthesitis index. PGA, patients' level of pain (pain VAS), EGA, and HAQ were also recorded. Grey scale (GS) and power Doppler (PD) ultrasound were performed at 68 joints (evaluating synovia and tendons) and 14 entheses. Regression analyses were performed to assess the association of these variables with PGA and EGA. Two new variables "PGAminusEGA" and "PGAchange - EGAchange" were developed to explore the discrepancy between PGA and EGA and the consistency of PGA/EGA changes over time, respectively.
RESULTS: The parameters explaining most of PGA and EGA variability were pain VAS (30.5%) and SJC (48.5%), respectively. The correlation between EGA and joint counts was stronger in patients with high vs. low levels of ultrasound verified inflammation. PGAminusEGA was mainly explained by pain and SJC. Pain was the most important predictor of PGA change whereas TJC and HAQ were more closely associated with EGA changes. "PGAchange-EGAchange" was linked to pain and SJC. Ultrasound scores were not linked with either of these variables.
CONCLUSIONS: Pain VAS and joint counts are the most important clinical parameters explaining patients' and physicians' perception of disease activity, whereas the correlation of active inflammation as verified by sonography with these factors is limited.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disease activity; Global assessment; Psoriatic arthritis; Ultrasound

Mesh:

Year:  2016        PMID: 27373500     DOI: 10.1016/j.semarthrit.2016.05.010

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

Review 1.  Disease activity indices in psoriatic arthritis: current and evolving concepts.

Authors:  Chrysoula G Gialouri; George E Fragoulis
Journal:  Clin Rheumatol       Date:  2021-05-18       Impact factor: 2.980

2.  Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study.

Authors:  Eleni Kampylafka; Isabelle d'Oliveira; Christina Linz; Veronika Lerchen; Fabian Stemmler; David Simon; Matthias Englbrecht; Michael Sticherling; Jürgen Rech; Arnd Kleyer; Georg Schett; Axel J Hueber
Journal:  Arthritis Res Ther       Date:  2018-07-27       Impact factor: 5.156

3.  DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs.

Authors:  Silva Pukšić; Pernille Bolton-King; Joseph Sexton; Brigitte Michelsen; Tore K Kvien; Hilde Berner Hammer
Journal:  RMD Open       Date:  2018-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.